Literature DB >> 19522022

Biochemical metabolic changes assessed by 31P magnetic resonance spectroscopy after radiation-induced hepatic injury in rabbits.

Ri-Sheng Yu1, Liang Hao, Fei Dong, Jian-Shan Mao, Jian-Zhong Sun, Ying Chen, Min Lin, Zhi-Kang Wang, Wen-Hong Ding.   

Abstract

AIM: To compare the features of biochemical metabolic changes detected by hepatic phosphorus-31 magnetic resonance spectroscopy ((31)P MRS) with the liver damage score (LDS) and pathologic changes in rabbits and to investigate the diagnostic value of (31)P MRS in acute hepatic radiation injury.
METHODS: A total of 30 rabbits received different radiation doses (ranging 5-20 Gy) to establish acute hepatic injury models. Blood biochemical tests, (31)P MRS and pathological examinations were carried out 24 h after irradiation. The degree of injury was evaluated according to LDS and pathology. Ten healthy rabbits served as controls. The MR examination was performed on a 1.5 T imager using a (1)H/(31)P surface coil by the 2D chemical shift imaging technique. The relative quantities of phosphomonoesters (PME), phosphodiesters (PDE), inorganic phosphate (Pi) and adenosine triphosphate (ATP) were measured. The data were statistically analyzed.
RESULTS: (1) Relative quantification of phosphorus metabolites: (a) ATP: there were significant differences (P < 0.05) (LDS-groups: control group vs mild group vs moderate group vs severe group, 1.83 +/- 0.33 vs 1.55 +/- 0.24 vs 1.27 +/- 0.09 vs 0.98 +/- 0.18; pathological groups: control group vs mild group vs moderate group vs severe group, 1.83 +/- 0.33 vs 1.58 +/- 0.25 vs 1.32 +/- 0.07 vs 1.02 +/- 0.18) of ATP relative quantification among control group, mild injured group, moderate injured group, and severe injured group according to both LDS grading and pathological grading, respectively, and it decreased progressively with the increased degree of injury (r = -0.723, P = 0.000). (b) PME and Pi; the relative quantification of PME and Pi decreased significantly in the severe injured group, and the difference between the control group and severe injured group was significant (P < 0.05) (PME: LDS-control group vs LDS-severe group, 0.86 +/- 0.23 vs 0.58 +/- 0.22, P = 0.031; pathological control group vs pathological severe group, 0.86 +/- 0.23 vs 0.60 +/- 0.21, P = 0.037; Pi: LDS-control group vs LDS-severe group, 0.74 +/- 0.18 vs 0.43 +/- 0.14, P = 0.013; pathological control group vs pathological severe group, 0.74 +/- 0.18 vs 0.43 +/- 0.14, P = 0.005) according to LDS grading and pathological grading, respectively. (c) PDE; there were no significant differences among groups according to LDS grading, and no significant differences between the control group and experimental groups according to pathological grading. (2) The ratio of relative quantification of phosphorus metabolites: significant differences (P < 0.05) (LDS-moderate group and LDS-severe group vs LDS-control group and LDS-mild group, 1.94 +/- 0.50 and 1.96 +/- 0.72 vs 1.43 +/- 0.31 and 1.40 +/- 0.38) were only found in PDE/ATP between the moderate injured group, the severe injured group and the control group, the mild injured group. No significant difference was found in other ratios of relative quantification of phosphorus metabolites.
CONCLUSION: (31)P MRS is a useful method to evaluate early acute hepatic radiation injury. The relative quantification of hepatic ATP levels, which can reflect the pathological severity of acute hepatic radiation injury, is correlated with LDS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19522022      PMCID: PMC2695887          DOI: 10.3748/wjg.15.2723

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

Review 1.  Applications of magnetic resonance spectroscopy to chronic liver disease.

Authors:  S D Taylor-Robinson
Journal:  Clin Med (Lond)       Date:  2001 Jan-Feb       Impact factor: 2.659

2.  Energy metabolism in patients with acute and chronic liver disease.

Authors:  B Schneeweiss; W Graninger; P Ferenci; S Eichinger; G Grimm; B Schneider; A N Laggner; K Lenz; G Kleinberger
Journal:  Hepatology       Date:  1990-03       Impact factor: 17.425

3.  In vivo 31P NMR spectroscopic changes during liver regeneration.

Authors:  K A Campbell; Y P Wu; V P Chacko; J V Sitzmann
Journal:  J Surg Res       Date:  1990-09       Impact factor: 2.192

4.  Non-invasive quantitation of human liver metabolites using image-guided 31P magnetic resonance spectroscopy.

Authors:  D J Meyerhoff; G S Karczmar; G B Matson; M D Boska; M W Weiner
Journal:  NMR Biomed       Date:  1990-02       Impact factor: 4.044

5.  The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C.

Authors:  Adrian K P Lim; Nayna Patel; Gavin Hamilton; Joseph V Hajnal; Robert D Goldin; Simon D Taylor-Robinson
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

6.  Utility of hepatic phosphorus-31 magnetic resonance spectroscopy in a rat model of acute liver failure.

Authors:  Ian R Corbin; Richard Buist; Jim Peeling; Manna Zhang; Julia Uhanova; Gerald K Minuk
Journal:  J Investig Med       Date:  2003-02       Impact factor: 2.895

7.  Regenerative activity and liver function following partial hepatectomy in the rat using (31)P-MR spectroscopy.

Authors:  Ian R Corbin; Richard Buist; Vyacheslav Volotovskyy; Jim Peeling; Manna Zhang; Gerald Y Minuk
Journal:  Hepatology       Date:  2002-08       Impact factor: 17.425

8.  Quantitative hepatic phosphorus-31 magnetic resonance spectroscopy in compensated and decompensated cirrhosis.

Authors:  I R Corbin; L N Ryner; H Singh; G Y Minuk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-06-10       Impact factor: 4.052

9.  Role of hypoxia in obesity-induced disorders of glucose and lipid metabolism in adipose tissue.

Authors:  Jun Yin; Zhanguo Gao; Qing He; Dequan Zhou; Zengkui Guo; Jianping Ye
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-12-09       Impact factor: 4.310

10.  Hepatic 31P MRS in rat models of chronic liver disease: assessing the extent and progression of disease.

Authors:  I R Corbin; R Buist; J Peeling; M Zhang; J Uhanova; G Y Minuk
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

View more
  1 in total

1.  Preliminary Study on Hepatocyte-Targeted Phosphorus-31 MRS Using ATP-Loaded Galactosylated Chitosan Oligosaccharide Nanoparticles.

Authors:  Ri-Sheng Yu; Xiu-Liang Zhu; Jian-Zhong Sun; Dan Shi; Ying Chen; Zhi-Kang Wang; Ke-Zhong Tang; Yong-Zhong Du
Journal:  Gastroenterol Res Pract       Date:  2013-12-02       Impact factor: 2.260

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.